Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Thursday, March 27, 2025.
Stock Region Penny Picks Watchlist Newsletter - Thursday, March 27, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Stock Region encourages readers to research and consult with a qualified financial advisor before making investment decisions.
$TDTH - Trident
Trident has announced a share repurchase program worth $1,000,000. This move could signal confidence in the company’s performance and long-term prospects.
$ALZN - Alzamend Neuro
Insider buying activity is noted as Director William B. Horne acquired 3,334 shares at $0.99 each. The current trading price stands at $1.00. Insider buying often reflects positive sentiment from within the company.
$WKSP - Worksport Ltd.
Worksport reported a significant 455% year-over-year revenue growth for fiscal year 2024.
$DRMA - Dermata Therapeutics
Dermata’s XYNGARI™ Phase 3 trial has met all primary endpoints, marking a significant step forward for its clinical development.
$CERO - CERo Therapeutics Holdings, Inc.
Following a positive FDA review, CERo is preparing to initiate enrollment for a Phase 1 trial of CER-1236 in AML. Positive regulatory updates often serve as catalysts for further developments.
$RGLS - Regulus Therapeutics
Regulus successfully completed its Phase 1b multiple-ascending dose clinical trial of Farabursen (RGLS8429) for treating Autosomal Dominant Polycystic Kidney Disease (ADPKD), progressing toward addressing this condition.
$CISO - CISO Global, Inc.
CISO has achieved profitability and anticipates at least $34 million in adjusted EBITDA profitable revenue for 2025, showcasing strong operational performance.
$NEOV - NeoVolta Inc.
NeoVolta projects record quarterly sales exceeding $2 million, representing over 600% year-over-year growth.
$ME - 23andMe
The company has received court approval to sell DNA data, sparking privacy debates amidst growing monetization strategies for genetic information.
$LAZR - Luminar
Luminar has teamed up with Caterpillar to develop industrial autonomous solutions, showcasing its expanding presence in the market beyond automotive applications.
$VVPR - VivoPower International
Trading was halted as VivoPower granted exclusivity to Energi, contingent upon increasing a non-binding all-cash takeover offer to an enterprise value of $180 million.
$ARBB - ARB IOT Group Limited
ARB IOT unveiled an AI-powered smart robot aimed at enhancing agricultural fertilization practices, presenting an innovative approach to precision farming.
$SNSE - Sensei Biotherapeutics
Sensei reported favorable preliminary dose expansion data for Solnerstotug in treating PD-(L)1 resistant tumors, positioning itself at the forefront of immunotherapy advancements.
$DLPN - Dolphin Entertainment
Dolphin reported a 20% year-over-year revenue growth to $51.7 million, alongside positive full-year adjusted operating income. Partner Loti AI expanded its digital identity protection services, strengthening Dolphin’s innovative offerings.
$PRTG - Portage Biotech
The company’s stock surged 66% to $7.83 after preclinical results for PORT-7 in mesothelioma showed promise, setting the stage for its first human trial.
$RNAZ - TransCode Therapeutics
TransCode announced the initial dosing in the fourth cohort of its Phase 1 clinical trial for TTX-MC138, continuing its development of novel therapeutic strategies.
Disclaimer: Stock Region is not responsible for any investment decisions made based on this newsletter. All investments carry risk, including potential loss of capital.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net